These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

573 related articles for article (PubMed ID: 11691937)

  • 1. Methyl-CpG-binding protein 2 represses LINE-1 expression and retrotransposition but not Alu transcription.
    Yu F; Zingler N; Schumann G; Strätling WH
    Nucleic Acids Res; 2001 Nov; 29(21):4493-501. PubMed ID: 11691937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methyl-CpG binding domain proteins and their involvement in the regulation of the MAGE-A1, MAGE-A2, MAGE-A3, and MAGE-A12 gene promoters.
    Wischnewski F; Friese O; Pantel K; Schwarzenbach H
    Mol Cancer Res; 2007 Jul; 5(7):749-59. PubMed ID: 17634428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. L1 retrotransposition in neurons is modulated by MeCP2.
    Muotri AR; Marchetto MC; Coufal NG; Oefner R; Yeo G; Nakashima K; Gage FH
    Nature; 2010 Nov; 468(7322):443-6. PubMed ID: 21085180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methyl-CpG-binding protein MeCP2 represses Sp1-activated transcription of the human leukosialin gene when the promoter is methylated.
    Kudo S
    Mol Cell Biol; 1998 Sep; 18(9):5492-9. PubMed ID: 9710633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MeCP2 is a transcriptional repressor with abundant binding sites in genomic chromatin.
    Nan X; Campoy FJ; Bird A
    Cell; 1997 Feb; 88(4):471-81. PubMed ID: 9038338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. L1 retrotransposition is activated by Ten-eleven-translocation protein 1 and repressed by methyl-CpG binding proteins.
    Zhang P; Ludwig AK; Hastert FD; Rausch C; Lehmkuhl A; Hellmann I; Smets M; Leonhardt H; Cardoso MC
    Nucleus; 2017 Sep; 8(5):548-562. PubMed ID: 28524723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MeCP2 driven transcriptional repression in vitro: selectivity for methylated DNA, action at a distance and contacts with the basal transcription machinery.
    Kaludov NK; Wolffe AP
    Nucleic Acids Res; 2000 May; 28(9):1921-8. PubMed ID: 10756192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methylation-dependent silencing at the H19 imprinting control region by MeCP2.
    Drewell RA; Goddard CJ; Thomas JO; Surani MA
    Nucleic Acids Res; 2002 Mar; 30(5):1139-44. PubMed ID: 11861904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MBD3L2 interacts with MBD3 and components of the NuRD complex and can oppose MBD2-MeCP1-mediated methylation silencing.
    Jin SG; Jiang CL; Rauch T; Li H; Pfeifer GP
    J Biol Chem; 2005 Apr; 280(13):12700-9. PubMed ID: 15701600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered chromatin structure associated with methylation-induced gene silencing in cancer cells: correlation of accessibility, methylation, MeCP2 binding and acetylation.
    Nguyen CT; Gonzales FA; Jones PA
    Nucleic Acids Res; 2001 Nov; 29(22):4598-606. PubMed ID: 11713309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex.
    Nan X; Ng HH; Johnson CA; Laherty CD; Turner BM; Eisenman RN; Bird A
    Nature; 1998 May; 393(6683):386-9. PubMed ID: 9620804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Active repression of methylated genes by the chromosomal protein MBD1.
    Ng HH; Jeppesen P; Bird A
    Mol Cell Biol; 2000 Feb; 20(4):1394-406. PubMed ID: 10648624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of LINE-1 mobility in neuroblastoma cells by in vitro retrotransposition reporter assay: FACS analysis can detect only the tip of the iceberg of the inserted L1 elements.
    Del Re B; Marcantonio P; Capri M; Giorgi G
    Exp Cell Res; 2010 Dec; 316(20):3358-67. PubMed ID: 20620136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Ski protein family is required for MeCP2-mediated transcriptional repression.
    Kokura K; Kaul SC; Wadhwa R; Nomura T; Khan MM; Shinagawa T; Yasukawa T; Colmenares C; Ishii S
    J Biol Chem; 2001 Sep; 276(36):34115-21. PubMed ID: 11441023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of Conserved Amino Acids in the C-Terminal Region of LINE-1 ORF2p in Retrotransposition.
    Christian CM; Sokolowski M; deHaro D; Kines KJ; Belancio VP
    Genetics; 2017 Mar; 205(3):1139-1149. PubMed ID: 28100588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Precipitous release of methyl-CpG binding protein 2 and histone deacetylase 1 from the methylated human multidrug resistance gene (MDR1) on activation.
    El-Osta A; Kantharidis P; Zalcberg JR; Wolffe AP
    Mol Cell Biol; 2002 Mar; 22(6):1844-57. PubMed ID: 11865062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The length of CpG islands is associated with the distribution of Alu and L1 retroelements.
    Kang MI; Rhyu MG; Kim YH; Jung YC; Hong SJ; Cho CS; Kim HS
    Genomics; 2006 May; 87(5):580-90. PubMed ID: 16488573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of transcription and chromatin by methyl-CpG binding protein MBD1.
    Nakao M; Matsui S; Yamamoto S; Okumura K; Shirakawa M; Fujita N
    Brain Dev; 2001 Dec; 23 Suppl 1():S174-6. PubMed ID: 11738867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methylation-mediated proviral silencing is associated with MeCP2 recruitment and localized histone H3 deacetylation.
    Lorincz MC; Schübeler D; Groudine M
    Mol Cell Biol; 2001 Dec; 21(23):7913-22. PubMed ID: 11689684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional consequences of Rett syndrome mutations on human MeCP2.
    Yusufzai TM; Wolffe AP
    Nucleic Acids Res; 2000 Nov; 28(21):4172-9. PubMed ID: 11058114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.